Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRS | BDX | MCK | ABC | ALGN |
| Company | Antares Pharma | Becton Dickinson and Company | Mckesson Corp | Amerisourcebergen Corp | Align Technology |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NASDAQ |
| Open | 5.58 | 232.33 | 531.64 | 180.93 | 310.65 |
| High | 5.60 | 234.57 | 537.15 | 180.93 | 315.77 |
| Low | 5.58 | 230.03 | 529.28 | 179.24 | 306.31 |
| Last | 5.59 | 233.83 | 535.42 | 179.98 | 313.78 |
| Change | unch | -0.53 | +3.42 | -0.41 | +1.90 |
| % Change | unch | -0.23% | +0.64% | -0.23% | +0.61% |
| Volume | 2,707,400 | 779,855 | 583,496 | 806,000 | 1,103,800 |
| 20-Day Average Volume | 3,885,230 | 1,054,220 | 520,865 | 2,493,280 | 592,010 |
| Previous Close | 5.59 | 234.36 | 532.00 | 180.39 | 311.88 |
| Industry | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers | Medical - Dental Suppliers |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.57 | 239.17 | 530.54 | 183.65 | 314.25 |
| 20-Day Raw Stochastic | 83.33% | 23.31% | 73.04% | 16.43% | 49.18% |
| 20-Day Relative Strength | 76.57% | 44.08% | 56.55% | 41.63% | 52.44% |
| Weighted Alpha | +30.00 | -12.09 | +44.91 | +20.60 | +16.36 |
| Today's Opinion | 100% Buy | 72% Sell | 88% Buy | 40% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 88% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 48% Sell | 100% Buy | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 05/16/22 | +0.70% since 04/17/24 | +1.81% since 04/17/24 | +1.14% since 08/22/23 | +4.54% since 04/17/24 |
| Low | 5.57 on 05/18/22 | 230.02 on 04/24/24 | 514.88 on 04/18/24 | 177.15 on 08/23/23 | 296.50 on 04/19/24 |
| High | 5.60 on 05/23/22 | 236.18 on 04/23/24 | 537.15 on 04/24/24 | 180.93 on 08/29/23 | 315.77 on 04/24/24 |
| 1-Month | |||||
| %Chg | +0.36% since 04/22/22 | -5.04% since 03/22/24 | +0.54% since 03/22/24 | -3.53% since 07/28/23 | -1.77% since 03/22/24 |
| Low | 5.54 on 05/12/22 | 229.40 on 04/17/24 | 514.88 on 04/18/24 | 177.15 on 08/23/23 | 296.50 on 04/19/24 |
| High | 5.60 on 05/23/22 | 248.42 on 03/28/24 | 543.00 on 04/04/24 | 194.37 on 08/03/23 | 331.64 on 04/11/24 |
| 3-Month | |||||
| %Chg | +65.88% since 02/23/22 | -0.32% since 01/24/24 | +10.40% since 01/24/24 | +6.87% since 05/26/23 | +22.06% since 01/24/24 |
| Low | 3.24 on 02/24/22 | 229.40 on 04/17/24 | 478.65 on 01/25/24 | 163.37 on 05/31/23 | 254.28 on 01/25/24 |
| High | 5.60 on 05/23/22 | 248.42 on 03/28/24 | 543.00 on 04/04/24 | 194.79 on 07/21/23 | 335.40 on 03/21/24 |
| 6-Month | |||||
| %Chg | +63.93% since 11/23/21 | -9.79% since 10/24/23 | +18.44% since 10/24/23 | +15.70% since 02/28/23 | +18.20% since 10/24/23 |
| Low | 3.11 on 01/28/22 | 229.40 on 04/17/24 | 431.35 on 12/15/23 | 147.48 on 03/15/23 | 176.34 on 10/30/23 |
| High | 5.60 on 05/23/22 | 262.23 on 10/25/23 | 543.00 on 04/04/24 | 194.79 on 07/21/23 | 335.40 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 955,063 | 67,707,072 | 69,909,056 | 36,387,456 | 23,469,592 |
| Shares Outstanding, K | 170,852 | 288,902 | 131,408 | 202,175 | 75,252 |
| Annual Sales | 183,980,000 | 19,372,000,000 | 276,711,000,000 | 238,587,000,000 | 3,862,260,000 |
| Annual Net Income | 46,290,000 | 1,484,000,000 | 3,560,000,000 | 1,698,820,000 | 445,050,000 |
| Last Quarter Sales | 41,560,000 | 4,706,000,000 | 80,898,000,000 | 66,947,050,000 | 956,730,000 |
| Last Quarter Net Income | -2,320,000 | 281,000,000 | 589,000,000 | 479,580,000 | 124,010,000 |
| 60-Month Beta | 1.15 | 0.43 | 0.45 | 0.56 | 1.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 05/10/22 | 2.68 on 02/01/24 | 7.74 on 02/07/24 | 2.92 on 08/02/23 | 2.42 on 01/31/24 |
| Latest Earnings Date | 05/19/22 | 05/02/24 | 05/07/24 | 08/02/23 | 04/24/24 |
| Most Recent Dividend | N/A | 0.950 on 03/07/24 | 0.620 on 02/29/24 | 0.485 on 08/10/23 | N/A |
| Next Ex-Dividends Date | N/A | 03/07/24 | 02/29/24 | 08/10/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 79.86 | 19.62 | 18.55 | 15.38 | 45.65 |